U.S. Markets close in 2 hrs 38 mins

Biotech weighs on S&P

CNBC's Dominic Chu reports the health care sector is being dragged down by the biotech sector. Congressional Democrats asked biotech company Gilead to provide insight on pricing for its hepatitis C drug Sovaldi.